Updated Today
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
As of March 25, 2026, the Kalshi odds for When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? are: before April 2027: 55%, before 2027: 50%, before December: 43%, before November: 37%, before October: 31%. These probabilities are derived from real-money trading and update in real time.
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? is currently available on Kalshi. Check PredictMarketCap for cross-platform availability as new markets are added regularly.
Prediction market odds reflect the aggregate opinion of traders who risk real money on outcomes. The price of a share (e.g., 65¢) represents the market's implied probability (65%). Prices move as traders buy and sell based on new information, polls, and analysis.